Moffitt logo

Clinical Trials Search

Clinical Trial 21885

Cancer Type: Gynecological Tumor
Study Type: Prevention
NCT#: NCT05645146

Phase: N/A
Principal Investigator: Vidrine, Jennifer

Call 813-745-6100
or 1-800-679-0775 Learn More

Study Title

Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)


The goal of this research study is to compare the efficacy of a treatment approach that comprises both Motivation And Problem-Solving (MAPS)-based telephone counseling and a personally-tailored SMS-delivered text-based approach to quitline-delivered smoking cessation treatment to help participants with a history of cervical cancer or high-grade cervical dysplasia quit smoking.


Primary Aim: Evaluate the efficacy of MAPS+ and ST in facilitating long-term smoking abstinence. Secondary Aim: Compare the magnitude of the mediated effects via common mechanisms (i.e., motivation, agency, and stress/negative affect) on smoking abstinence between the MAPS+ and ST treatment groups.




Inclusion Criteria

Inclusion Criteria:

  • At least 100 cigarettes or more smoked in participants lifetime
  • Speaks English
  • Currently smoke 1 cigarette or more in the past 30 days
  • History of cervical cancer or high-grade cervical dysplasia
  • Has a working smartphone
  • Has a valid home address in the State of Florida

  • Exclusion Criteria

    Exclusion Criteria:

  • Medical condition precluding nicotine replacement therapy
  • Receiving behavioral or pharmacological tobacco treatment
  • Household member enrolled in this study

  • If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.